These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5566455)

  • 1. [Intracellular repercussions of alkaline therapy in chronic uremic patients].
    Acquarone N; Bertocchi I; De Ferrari G; Guerreri G; Menozzi PG; Tizianello A
    Minerva Nefrol; 1971; 18(2):102-9. PubMed ID: 5566455
    [No Abstract]   [Full Text] [Related]  

  • 2. Acidosis in uremic patients.
    Bommer J; Keller C; Gehlen F; Hergesell O
    Clin Nephrol; 1996 Oct; 46(4):280-5. PubMed ID: 8905222
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of metabolic acidosis in causing uremic hyperphosphatemia.
    Barsotti G; Lazzeri M; Cristofano C; Cerri M; Lupetti S; Giovannetti S
    Miner Electrolyte Metab; 1986; 12(2):103-6. PubMed ID: 3007964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate.
    Flanigan M
    J Am Soc Nephrol; 1993 Nov; 4(5):1219-20. PubMed ID: 8135952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of improved levels of plasma bicarbonates in terminal renal failure].
    Melamed J; Kramer I; Kuhlencordt M; Botterman P; Kopp KF
    Nephrologie; 1983; 4(4-5):236-7. PubMed ID: 6320024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acidosis in end-stage renal failure.
    Leunissen KM
    Blood Purif; 1995; 13(6):358-60. PubMed ID: 8821200
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythrocyte adenosine triphosphate depletion during hypophosphatemia in a uremic subject.
    Lichtman MA; Miller DR; Freeman RB
    N Engl J Med; 1969 Jan; 280(5):240-4. PubMed ID: 4236189
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative effects of THAM (tris-hydroxymethyl-amino-methane) and sodium bicarbonate in the therapy of renal acidosis].
    Poli D; Maschio G; Todesco S; Mioni G; Bazzato G; Riz G
    Minerva Nefrol; 1968; 15(4):267-72. PubMed ID: 5745817
    [No Abstract]   [Full Text] [Related]  

  • 9. How to achieve optimal correction of acidosis in end-stage renal failure patients.
    Zucchelli P; Santoro A
    Blood Purif; 1995; 13(6):375-84. PubMed ID: 8821203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of acetate and bicarbonate in the treatment of uremic acidosis.
    Feng PH; Weinberg U; Reisin E; Iaina A; Eliahou HE
    Isr J Med Sci; 1970; 6(6):732-4. PubMed ID: 5512593
    [No Abstract]   [Full Text] [Related]  

  • 11. Derangement of acid-base balance in uremia and under hemodialysis.
    Messa P; Mioni G; Maio GD; Ferrando C; Lamperi D; Famularo A; Paoletti E; Cannella G
    J Nephrol; 2001; 14 Suppl 4():S12-21. PubMed ID: 11798141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of bicarbonate dialysis.
    Mastrangelo F; Rizzelli S; Corliano C; Montinaro AM; De Blasi V; Alfonso L; Aprile M; Napoli M; Laforgia R
    Kidney Int Suppl; 1985 Dec; 17():S188-93. PubMed ID: 3867794
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic uremia.
    Hampers CL
    Mod Treat; 1969 Sep; 6(5):1036-63. PubMed ID: 5361631
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research on some erythrocytic abnormalities in chronic uremic patients in conservative and dialytic therapy].
    Lamperi S; Sitia L; Bandiani G; Muttini P
    Minerva Nefrol; 1970; 17(6):175-80. PubMed ID: 5516050
    [No Abstract]   [Full Text] [Related]  

  • 16. Acid-base balance and oxygen tension during dialysis in uremic patients with chronic obstructive pulmonary disease.
    Manca-Di-Villahermosa S; Tedesco M; Lonzi M; Della-Rovere FR; Innocenzi A; Colarieti G; Favarò A; Chamoun GM; Taccone-Gallucci M
    Artif Organs; 2008 Dec; 32(12):973-7. PubMed ID: 19133027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adsorbents in the treatment of uremia. Hemoperfusion plus hemodialysis].
    Stalteri A; Rapisarda LM; Battiati E; Galione A; Picone F; Falco M; Romano M
    Minerva Nefrol; 1979; 26(2):217-20. PubMed ID: 471354
    [No Abstract]   [Full Text] [Related]  

  • 18. [The influence of twice-weekly hemodialytic treatment on the hypertensive syndrome in chronic uremic patients].
    Cioni L; Biagini M; Gloria E; Pentimone F
    Minerva Nefrol; 1966; 13(4):112-5. PubMed ID: 5995530
    [No Abstract]   [Full Text] [Related]  

  • 19. Muscle intracellular electrolytes in patients with chronic uremia.
    Bergström J; Alvestrand A; Fürst P; Hultman E; Widstam-Attorps U
    Kidney Int Suppl; 1983 Dec; 16():S153-60. PubMed ID: 6588246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodialysis and social recovery of chronic uremic patients].
    Cortesini R
    Minerva Nefrol; 1967; 14(4):193-5. PubMed ID: 5607561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.